Drug Shortage Report for CEFTRIAXONE FOR INJECTION

Last updated on 2021-11-24 History
Report ID 143328
Drug Identification Number 02409968
Brand name CEFTRIAXONE FOR INJECTION
Common or Proper name CefTRIAXone for Injection 100 g SmartPak®
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 100G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size SmartPak
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-11-01
Actual start date 2021-11-01
Estimated end date 2021-12-20
Actual end date
Shortage status Actual shortage
Updated date 2021-11-24
Company comments Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our CefTRIAXone for Injection 100 g SmartPak®.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-11-24 French Compare
v11 2021-11-24 English Compare
v10 2021-11-02 English Compare
v9 2021-10-27 French Compare
v8 2021-10-27 English Compare
v7 2021-10-27 French Compare
v6 2021-10-27 English Compare
v5 2021-08-31 French Compare
v4 2021-08-31 English Compare
v3 2021-08-02 English Compare
v2 2021-07-30 French Compare
v1 2021-07-30 English Compare